Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo
Authors
Keywords
Hepatocellular carcinoma, Mesenchymal stem cells, Apoptin, Inhibitory
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 416, Issue 1-2, Pages 193-203
Publisher
Springer Nature
Online
2016-05-03
DOI
10.1007/s11010-016-2707-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural biology of Tat protein transport
- (2014) Ben C Berks et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Transduced protein transduction domain linked HSP27 protected LECs against UVB radiation-induced damage
- (2014) Lian Liu et al. EXPERIMENTAL EYE RESEARCH
- Inhibitory effect of ibuprofen on tumor survival and angiogenesis in gastric cancer cell
- (2014) Hassan Akrami et al. TUMOR BIOLOGY
- Long-Term Outcome of the First 150 Liver Transplant Recipients: A Single-Center Experience
- (2013) S.N. Sintra et al. TRANSPLANTATION PROCEEDINGS
- Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells
- (2013) Lingling Hou et al. TUMOR BIOLOGY
- Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and ΔNp73 isoforms through ubiquitin ligase PIR2
- (2012) P. Taebunpakul et al. APOPTOSIS
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity
- (2011) S H Seo et al. GENE THERAPY
- The changing pattern of epidemiology in hepatocellular carcinoma
- (2010) Helena Nordenstedt et al. DIGESTIVE AND LIVER DISEASE
- Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma
- (2009) Peng Gao et al. CANCER LETTERS
- Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
- (2009) M. R. Loebinger et al. CANCER RESEARCH
- Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model
- (2009) E. K. Mader et al. CLINICAL CANCER RESEARCH
- Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNγ-transduced tumor cell immunotherapy of experimental glioma
- (2009) Salina Gunnarsson et al. JOURNAL OF NEUROIMMUNOLOGY
- Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
- (2009) L. S. Sasportas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
- (2008) Ling Qiao et al. CELL RESEARCH
- Stem Cell Therapy for Liver Disease: Parameters Governing the Success of Using Bone Marrow Mesenchymal Stem Cells
- (2008) Tom K. Kuo et al. GASTROENTEROLOGY
- Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model
- (2008) C Ren et al. GENE THERAPY
- The C-terminus of apoptin represents a unique tumor cell-enhanced nuclear targeting module
- (2008) Henna V. Kuusisto et al. INTERNATIONAL JOURNAL OF CANCER
- Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare
- (2008) Maarten F Corsten et al. LANCET ONCOLOGY
- A Tumor-selective Biotherapy With Prolonged Impact on Established Metastases Based on Cytokine Gene-engineered MSCs
- (2008) Xiancheng Chen et al. MOLECULAR THERAPY
- Therapeutic Potential of Mesenchymal Stem Cells Producing Interferon-α in a Mouse Melanoma Lung Metastasis Model
- (2008) Changchun Ren et al. STEM CELLS
- Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit?
- (2008) Gwendal Lazennec et al. STEM CELLS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started